Sir Richard Sykes (L), Chairman of Glaxo Wellcome takes a closer look at the name board as Jean-Pierre Garnier Chief Executive Officer elect of Smithkline Beecham looks on following a news conference January 17 on the proposed merger of Glaxo Wellcome and Smithkline Beecham. The two British companies, which tried and failed to merge two years ago, said the deal, worth #114 billion, would give the the scientific and financial clout to be the most efficient drug discovery and marketing machine in the industry.

DJM/PS/ME